Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[A Case of Colostomy-Free and Long-Term Survival with 5-FU/CDDP for Local Recurrence of Anal Cancer after Chemoradiation Therapy].

Aoyama Y, Katada T, Saito M, Tsuchiya T, Nishido T, Kato A, Shibata T, Shibata T, Teranishi F, Sakamoto S, Mita K, Karamatsu S, Hikosaka Y, Nishida T.

Gan To Kagaku Ryoho. 2019 Mar;46(3):523-525. Japanese.

PMID:
30914602
2.

Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.

Doci R, Zucali R, La Monica G, Meroni E, Kenda R, Eboli M, Lozza L.

J Clin Oncol. 1996 Dec;14(12):3121-5.

PMID:
8955657
3.

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG.

J Clin Oncol. 2012 Dec 10;30(35):4344-51. doi: 10.1200/JCO.2012.43.8085. Epub 2012 Nov 13.

4.

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.

Cho BC, Ahn JB, Seong J, Roh JK, Kim JH, Chung HC, Sohn JH, Kim NK.

BMC Cancer. 2008 Jan 15;8:8. doi: 10.1186/1471-2407-8-8.

5.

Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study.

Peiffert D, Seitz JF, Rougier P, François E, Cvitkovic F, Mirabel X, Nasca S, Ducreux M, Hannoun-Levi JM, Lusinchi A, Debrigode E, Conroy T, Pignon JP, Gérard JP.

Ann Oncol. 1997 Jun;8(6):575-81.

PMID:
9261527
6.

Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases?

Grabenbauer GG, Matzel KE, Schneider IH, Meyer M, Wittekind C, Matsche B, Hohenberger W, Sauer R.

Dis Colon Rectum. 1998 Apr;41(4):441-50.

PMID:
9559628
7.

Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.

Oliveira SC, Moniz CM, Riechelmann R, Alex AK, Braghirolli MI, Bariani G, Nahas C, Hoff PM.

J Gastrointest Cancer. 2016 Mar;47(1):75-81. doi: 10.1007/s12029-015-9790-4.

PMID:
26691173
9.

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study.

Peiffert D, Giovannini M, Ducreux M, Michel P, François E, Lemanski C, Mirabel X, Cvitkovic F, Luporsi E, Conroy T, Gérard JP; Digestive Tumours Group of the French 'Fédération Nationale des Centres de Lutte Contre le Cancer'.

Ann Oncol. 2001 Mar;12(3):397-404.

PMID:
11332154
10.

Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.

Grabenbauer GG, Kessler H, Matzel KE, Sauer R, Hohenberger W, Schneider IH.

Dis Colon Rectum. 2005 Sep;48(9):1742-51.

PMID:
15991058
11.

Definitive chemoradiotherapy for anal canal cancer: single-center experience.

Tachibana I, Nishimura Y, Inada M, Fukuda K, Ishikawa K, Nishikawa T, Yokokawa M, Nakamatsu K, Kanamori S, Hida JI.

Int J Clin Oncol. 2018 Dec;23(6):1121-1126. doi: 10.1007/s10147-018-1316-1. Epub 2018 Jul 10.

PMID:
29992389
12.

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).

Matzinger O, Roelofsen F, Mineur L, Koswig S, Van Der Steen-Banasik EM, Van Houtte P, Haustermans K, Radosevic-Jelic L, Mueller RP, Maingon P, Collette L, Bosset JF; EORTC Radiation Oncology and Gastrointestinal Tract Cancer Groups.

Eur J Cancer. 2009 Nov;45(16):2782-91. doi: 10.1016/j.ejca.2009.06.020. Epub 2009 Jul 28.

PMID:
19643599
13.

Review of anal cancer patients at the Ottawa hospital.

Abunassar M, Reinders J, Jonker DJ, Asmis T.

Eur J Surg Oncol. 2015 May;41(5):653-8. doi: 10.1016/j.ejso.2015.02.004. Epub 2015 Mar 4.

PMID:
25776438
14.
15.

Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.

Sebag-Montefiore D, Meadows HM, Cunningham D, Plowman PN, Hurman DC, Davidson N, Grieve R, Levine E, Glynne-Jones R.

Radiother Oncol. 2012 Aug;104(2):155-60. doi: 10.1016/j.radonc.2012.06.006. Epub 2012 Aug 1.

PMID:
22857859
16.

Combined chemoradiation therapy for anal cancer. A report of 56 cases.

Doci R, Zucali R, Bombelli L, Montalto F, Lamonica G.

Ann Surg. 1992 Feb;215(2):150-6.

17.

Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort.

Jones CM, Adams R, Downing A, Glynne-Jones R, Harrison M, Hawkins M, Sebag-Montefiore D, Gilbert DC, Muirhead R.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1202-1211. doi: 10.1016/j.ijrobp.2018.04.033. Epub 2018 Apr 19.

18.

[Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].

Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Hannoun L, Houry S, Huguet F, Pène F, Parc R, Schlienger M.

Cancer Radiother. 2006 Dec;10(8):572-82. Epub 2006 Nov 15. French.

PMID:
17110148
19.

[Outcomes of Anal Squamous Cell Carcinoma Treated with Chemoradiotherapy].

Sato H, Koide Y, Shiota M, Mizuno M, Morise Z, Uyama I.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1907-1909. Japanese.

PMID:
30692394
20.

EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.

Glynne-Jones R, Meadows H, Wan S, Gollins S, Leslie M, Levine E, McDonald AC, Myint S, Samuel L, Sebag-Montefiore D; National Cancer Research Institute Anal Sub Group and Colorectal Clinical Oncology Group.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):119-26. doi: 10.1016/j.ijrobp.2007.12.012. Epub 2008 May 9.

PMID:
18472366

Supplemental Content

Support Center